Nvidias Earnings Highlight 200 Billion Opportunity and Edge Computing Despite China Concession SpaceX S1 Reveals AI Infrastructure Economics 27M Per Megawatt Build Cost 15B Anthropic Contract Meta Settles Landmark Social Media Addiction Lawsuit with US School District Sets Precedent for Hundreds of Similar Cases London Stock Exchange Group Reports Income Growth Driven by Tradeweb Performance Micron Breaches 1 Trillion Market Cap Milestone as AIDriven Memory Shortage Lifts Stock 19 Paul Tudor Jones Dismisses Possibility of Fed Rate Cuts Under Warsh Leadership EZRA Q1 2023 Earnings Massive EPS Surprise of 324 Against Negative Estimate Revenue Unreported SKYT Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges SES AI Corporation Q1 2026 Earnings EPS Misses Estimates Amid Continued PreRevenue Phase Kalaris Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Biotech TGT Q1 2026 Earnings EPS of 171 Highlights Resilient Operations Amid Modest Stock Decline Nuveen Churchill Direct Lending Corp NCDL Holds Steady Near Support Amid Modest Gains KNRX Faces Pressure Knorex Ltd Tests Key Support Levels After 263 Decline ProCap Financial Warrants BRRWW Consolidate at 021 as Price Action Remains RangeBound XOMA Royalty Holds Near Support Following Minor Decline SELLAS Life Sciences Group SLS Surges 629 as Biotech Momentum Builds SRPT Q1 2026 Earnings EPS Surges 18467 Above Estimates Amid Strong Gene Therapy Progress USEG Q1 2026 Earnings EPS Misses Estimates by 96 Stock Surges Over 10 OBIO Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline in PreRevenue Phase Nakamoto Inc NAKA Q4 2025 Earnings EPS Misses Estimates but Stock Surges 915 AGAE Q1 2025 Earnings Negative EPS of 011 Amid Silent Guidance and Market Decline WEBTOON Entertainment WBTN Q1 2026 Earnings NarrowerThanExpected Loss Drives Shares Slightly Lower Fed Dissenters Push Back Against RateCut Signal Citing Policy Uncertainty SBC Medical Group Holdings Q1 2026 Earnings EPS Beat Amid Market Skepticism BeOne Medicines ONC Edges Higher Amid Sector Volatility Key Levels in Focus